Alexandria, VA, United States of America

Marian Elaine Major


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2004-2017

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Marian Elaine Major: Innovator in Hepatitis C Research

Introduction

Marian Elaine Major is a prominent inventor based in Alexandria, VA (US), known for her significant contributions to the field of virology, particularly in hepatitis C research. With a total of six patents to her name, she has made remarkable strides in developing neutralizing antibodies against the hepatitis C virus.

Latest Patents

Among her latest patents are groundbreaking discoveries related to hepatitis C virus neutralizing antibodies and methods. One patent identifies novel epitope regions on the hepatitis C virus E1E2 glycoprotein that induce a neutralizing antibody response in vivo. This patent also discloses cross-neutralizing monoclonal antibodies that specifically bind to these epitopes. Another patent focuses on a specific epitope on the surface of the hepatitis C virus that induces a neutralizing antibody response in vivo, along with monoclonal antibodies that block the virus from infecting cells.

Career Highlights

Marian has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the State Research Center of Virology and Biotechnology "Vector." Her work in these institutions has been pivotal in advancing research on hepatitis C.

Collaborations

Throughout her career, Marian has collaborated with notable scientists, including Stephen M. Feinstone and Jay A. Berzofsky. These collaborations have further enriched her research and contributed to the scientific community's understanding of hepatitis C.

Conclusion

Marian Elaine Major's innovative work in hepatitis C research has led to significant advancements in the development of neutralizing antibodies. Her contributions continue to impact the field and offer hope for effective treatments against hepatitis C.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…